ACI Bolsters Regulatory and Compliance Unit To Support UK CBD Industry
The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.
FSA Clarifies ACI Questions Concerning CBD Novel Foods Applications
The ACI have received clarification from the FSA on several points concerning novel foods dossier applications that have been raised by our members.
The ACI Lays the Foundation for the Harmonisation of Cannabinoid Testing
The ACI announces high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on the development of a cannabinoid testing methodology with a higher precision control, an essential step towards standardisation for the industry.
The ACI Announces CBD Novel Foods Symposium
2pm BST, Wednesday 27 May 2020
With the new novel foods regulation deadline looming this event will provide a unique opportunity to listen and engage with representatives of the UK’s regulator the Foods Standards Agency as well as industry experts from trading standards, toxicology, and the analytical testing and legal worlds.
The ACI Launches Free 0800 Helpline for CBD Companies
The Association for the Cannabinoid Industry today launched a free helpline for CBD companies wanting to continue operations in the UK after the FSA’s deadline of 31 March 2021.
Novel Foods CBD Dossier Timeline
The purpose of this timeline is to highlight the importance that CBD companies must start the process of Novel Foods applications now in order to avoid disruption in their distribution channels when FSA regulations come into force. We include the data required in a Novel Foods dossier followed by an estimate of time to produce this data.
Academic Paper: An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom
The ACI is pleased to announce the publication of the peer-reviewed academic paper entitled “An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom”. Two of the paper’s authors are part of the team of experts forming The ACI, Professor Saoirse O’Sullivan and Dr Andy Yates. “In this independent study, we blind tested over the […]
The ACI Announces First Member to Submit Novel Foods CBD Dossier
The ACI congratulate Mile High Labs on the submission of their CBD Novel Foods dossier to the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA).
FSA Confirms No Plans To Extend 31 March 2021 Deadline for CBD Companies
The Food Standards Agency (FSA) confirmed last week, in a virtual meeting with the Association for the Cannabinoid Industry (The ACI), that they intend to stick to their deadline of 31 March 2021 for CBD companies to have a validated Novel Foods application.
The Association for the Cannabinoid Industry Launches New CBD Safety Certification Initiative
The ACI today outlined new plans for The ACI Safety Certification programme. Launched exactly one year before the FSA’s new safety regulations come into force, which excludes all CBD food products from sale in the UK without a validated Novel Foods application dossier.